CHEMBIO DIAGNOSTICS INC's ticker is CEMI and the CUSIP is 163572209. A total of 38 filers reported holding CHEMBIO DIAGNOSTICS INC in Q2 2022. The put-call ratio across all filers is 3.21 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,000 | +99900.0% | 1,493 | -57.6% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 3,520 | +3.7% | 0.00% | – |
| Q3 2022 | $1,000 | -66.7% | 3,394 | -12.8% | 0.00% | – |
| Q2 2022 | $3,000 | -25.0% | 3,894 | -13.3% | 0.00% | – |
| Q1 2022 | $4,000 | -89.5% | 4,493 | -86.6% | 0.00% | – |
| Q4 2021 | $38,000 | +850.0% | 33,452 | +2264.1% | 0.00% | – |
| Q3 2021 | $4,000 | -98.5% | 1,415 | -98.5% | 0.00% | – |
| Q2 2021 | $274,000 | -18.0% | 92,364 | -2.8% | 0.00% | – |
| Q1 2021 | $334,000 | +695.2% | 94,989 | +986.1% | 0.00% | – |
| Q4 2020 | $42,000 | +20.0% | 8,746 | +18.8% | 0.00% | – |
| Q3 2020 | $35,000 | +66.7% | 7,364 | +12.4% | 0.00% | – |
| Q2 2020 | $21,000 | -85.6% | 6,554 | -75.2% | 0.00% | – |
| Q1 2019 | $146,000 | +2.1% | 26,395 | +4.2% | 0.00% | – |
| Q4 2018 | $143,000 | – | 25,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Penbrook Management LLC | 344,060 | $1,634,000 | 1.26% |
| Union Square Park Capital Management, LLC | 400,000 | $1,900,000 | 0.76% |
| P.A.W. CAPITAL CORP | 100,000 | $475,000 | 0.42% |
| PRECEPT MANAGEMENT LLC | 150,000 | $713,000 | 0.29% |
| Newbridge Financial Services Group, Inc. | 73,500 | $349,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 183,584 | $990,000 | 0.22% |
| FRIESS ASSOCIATES LLC | 555,000 | $2,636,000 | 0.19% |
| PERRITT CAPITAL MANAGEMENT INC | 30,651 | $146,000 | 0.09% |
| Ikarian Capital, LLC | 219,109 | $1,041,000 | 0.05% |
| SEGALL BRYANT & HAMILL, LLC | 705,823 | $3,352,000 | 0.04% |